# CVE-2026-83193: Privilege escalation in Siebel Apps - Life Sciences

> A low-privileged attacker with local access can escalate privileges to take over Siebel Apps - Life Sciences via a vulnerability requiring user interaction.

- **Severity:** High 7.3 (`CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Local or same network only
- **Victim action needed:** A user has to click or open something
- **Fix available:** No
- **Published:** 15 Sep 2026
- **Updated:** 17 Sep 2026
- **Also known as:** GHSA-x235-c59q-95cr

## What is CVE-2026-83193?

CVE-2026-83193 is a high-severity vulnerability in Oracle Corporation Siebel Apps - Life Sciences, published on 15 Sep 2026. It can only be exploited from the same machine or local network, and only if a user opens a file or follows a link.

### Official description

Vulnerability in the Siebel Apps - Life Sciences product of Oracle Siebel CRM (component: Life Sciences).  Supported versions that are affected are 17.0-26.7. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Siebel Apps - Life Sciences executes to compromise Siebel Apps - Life Sciences.  Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in takeover of Siebel Apps - Life Sciences. CVSS 3.1 Base Score 7.3 (Confidentiality, Integrity and Availability impacts).  CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H).

Weakness: CWE-269 (Improper Privilege Management)

## Which versions are affected by CVE-2026-83193?


## How do I fix CVE-2026-83193?

No fix has been published for CVE-2026-83193 yet. Limit exposure of the affected software until one is available.

## Is CVE-2026-83193 being exploited?

There is no known exploitation of CVE-2026-83193 in the wild and no public exploit code.

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2026-83193 and fix it if it is affected.

What it is: CVE-2026-83193 is a high-severity vulnerability in Oracle Corporation Siebel Apps - Life Sciences, published on 15 Sep 2026. It can only be exploited from the same machine or local network, and only if a user opens a file or follows a link.
Exploitation: There is no known exploitation of CVE-2026-83193 in the wild and no public exploit code.

Affected product: Oracle Corporation Siebel Apps - Life Sciences. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2026-83193/ (Markdown: https://insights.sbomify.com/CVE-2026-83193/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2026-83193
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2026-83193
- OSV: https://osv.dev/vulnerability/CVE-2026-83193

---
From sbomify Insights: https://insights.sbomify.com/CVE-2026-83193/
Summaries are generated and may contain mistakes; the official description above is the record.